E. Siegel

发表

Patient versus clinician symptom reporting using the National Cancer Institute Common Terminology Criteria for Adverse Events.

M. Kris, E. Basch, H. Scher, 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

A Phase II Study of Intravenous Exatecan Administered Daily for 5 Days, Every 3 Weeks to Patients With Biliary Tract Cancers

G. Abou-Alfa, G. Schwartz, Sunil Sharma, 2005, American journal of clinical oncology.